Financial Data and Key Metrics Changes - Free cash flow for 2025 was reported at -$88 million, indicating a need for improvement in cash generation [4] - The company carries high-cost debt, which is unsustainable under current conditions [4] Business Line Data and Key Metrics Changes - In the Cellulose Specialties segment, 85% of the business has achieved an average price increase of 18% over 2025, with an expected volume loss of about 20% [5] - The remaining 15% of the specialties business is still under discussion for potential price increases [5][6] Market Data and Key Metrics Changes - The ethers-grade cellulose market is facing challenges due to increased competition from Chinese producers, particularly in Europe, but the company has still managed to achieve near 20% price increases [26] - The nitration-grade cellulose market is experiencing increased demand from domestic producers of propellants, with price increases exceeding 18% [27] Company Strategy and Development Direction - The company aims to deliver positive free cash flow in 2026 as a top priority [5] - A focus on asserting leadership in Cellulose Specialties and improving EBITDA across all business lines is emphasized [6][8] - The company plans to implement a more integrated model across its product lines to optimize contribution margins and drive down fixed costs [51] Management's Comments on Operating Environment and Future Outlook - Management expresses confidence in the team's ability to drive free cash flow and improve operational performance [11] - There is a recognition of the need for higher pricing to ensure the sustainability of domestic producers in the Cellulose Specialties market [12][13] - The company is actively working on plans to enhance its Biomaterials segment, which is seen as a key growth area [32] Other Important Information - The company has a crisis management team in place to address production issues at the Tartas plant, which is crucial for the Biomaterials business [34] - There are ongoing antidumping cases that could positively impact pricing in North America, with preliminary determinations expected soon [36][37] Q&A Session Summary Question: Confidence in underlying earnings power and long-term shareholder value - Management highlights the team's capability and the significant value opportunities within the company, with plans to provide more details in future earnings calls [11] Question: Perspective on rejected potential offer and independent company strategy - Management refrains from commenting on specific offers but emphasizes plans that will deliver more value as an independent company [19] Question: Demand conditions and market competition - Management acknowledges challenges in the ethers-grade cellulose market due to competition but notes successful price increases [26] Question: Strategy for Biomaterials and impact on BioNova joint venture - Management views Biomaterials as an important growth contributor and plans to integrate it with other product lines for better value creation [32] Question: Pricing restoration timeline and antidumping case updates - Management is optimistic about restoring prices with or without antidumping duties, with preliminary determinations expected soon [36] Question: Long-term role of Paperboard and High-Yield Pulp businesses - Management states that all business segments are sources of improvement and will not be divested, with new products expected to drive growth [42]

Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $353 million, a decrease of $48 million year-over-year [24] - Operating income improved to $9 million, an increase of $26 million compared to the prior year [24] - Adjusted EBITDA was $42 million, down $9 million from Q3 2024 [25] - Adjusted free cash flow year-to-date was negative $83 million, with expectations for improvement in Q4 [25] Business Line Data and Key Metrics Changes - **Cellulose Specialties**: Quarterly net sales were $204 million, down 12% year-over-year, with a 17% decrease in sales volumes but a 7% increase in average sales prices [26] - **Biomaterials**: Quarterly net sales were $8 million, flat compared to the prior year, with operating income decreasing to $1 million [28] - **Cellulose Commodities**: Quarterly net sales were $85 million, down 1% from the prior year, with an operating loss of $13 million [30] - **Paperboard**: Quarterly net sales were $39 million, down 29% year-over-year, with an operating loss of $4 million [31] - **High-Yield Pulp**: Quarterly net sales were $24 million, down 14% compared to the prior year, with an operating loss of $10 million [32] Market Data and Key Metrics Changes - The company faced increased competition in the paperboard market due to new U.S. capacity and EU imports, leading to lower sales volumes and pricing [25][31] - The U.S. FLUF industry exports to China were impacted by a 10% tariff, affecting market dynamics [5][6] Company Strategy and Development Direction - The company aims to increase EBITDA to over $300 million by exiting 2027, focusing on cash generation and capital investment discipline [4] - A significant pricing reset for cellular specialty products is targeted to recapture lost value from inflation [12][42] - The company is pursuing new product development to enhance profitability and market position [10][14] Management's Comments on Operating Environment and Future Outlook - Management believes that the temporary headwinds of 2025 are largely behind, with core business performance stabilizing [57] - The company is confident in achieving a significant pricing reset and improving EBITDA margins through organic growth [23][42] - Management highlighted the importance of achieving positive EBITDA and cash flow for the viability of certain assets before potential divestiture [35][36] Other Important Information - The company has $40 million of committed green debt available to support biomaterials projects [32] - The Altamaha Green Energy project is expected to generate significant returns, with a focus on securing funding [17][46] Q&A Session Summary Question: What operational and financial milestones are needed for paperboard and high-yield pulp assets to be viable for sale? - Management indicated that achieving positive EBITDA and cash flow, along with the completion of USMCA negotiations, are critical milestones [35][36] Question: How does the company plan to refinance given the current leverage ratio? - Management noted that demonstrating a return to historical EBITDA levels will improve leverage profiles and facilitate refinancing [37][38] Question: What is the expected impact of pricing negotiations on future EBITDA? - A 1% increase in pricing is expected to generate an $8 million to $9 million increase in EBITDA, with significant pricing increases needed to recapture lost value from inflation [39][42] Question: Can you elaborate on the new fluff product that avoids tariffs? - The new product is a dissolving wood pulp product that can bypass tariffs, but cost efficiency in production remains a challenge [51][52] Question: What are the major buckets for the additional $20 million in EBITDA improvement projects? - The focus will be on improving reliability, material usage, and implementing automation and predictive maintenance [53][54]